SHALBY
|
SHALBY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.83 | 6.31 | 5.01 | 3.93 | 2.55 |
| CEPS(Rs) | 12.64 | 10.79 | 8.97 | 7.33 | 5.89 |
| DPS(Rs) | 1.20 | 1.20 | 1.00 | 1.00 | 0.50 |
| Book NAV/Share(Rs) | 93.06 | 86.37 | 81.13 | 77.28 | 74.00 |
| Tax Rate(%) | 34.86 | 33.68 | 31.81 | 23.06 | 51.37 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.13 | 17.17 | 17.39 | 20.27 | 17.00 |
| EBIT Margin(%) | 15.62 | 13.99 | 12.40 | 13.83 | 13.17 |
| Pre Tax Margin(%) | 13.73 | 12.68 | 11.32 | 12.78 | 11.65 |
| PAT Margin (%) | 8.94 | 8.41 | 7.72 | 9.83 | 5.67 |
| Cash Profit Margin (%) | 14.54 | 14.38 | 13.86 | 18.37 | 13.06 |
| Performance Ratios | |||||
| ROA(%) | 5.37 | 5.06 | 4.60 | 4.05 | 2.72 |
| ROE(%) | 8.67 | 7.51 | 6.31 | 5.19 | 3.49 |
| ROCE(%) | 12.23 | 10.72 | 9.08 | 6.85 | 7.49 |
| Asset Turnover(x) | 0.60 | 0.60 | 0.60 | 0.41 | 0.48 |
| Sales/Fixed Asset(x) | 0.85 | 0.91 | 0.84 | 0.54 | 0.63 |
| Working Capital/Sales(x) | 4.08 | 2.49 | 2.59 | 2.28 | 3.24 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.18 | 1.10 | 1.19 | 1.84 | 1.59 |
| Receivable days | 49.06 | 47.01 | 51.09 | 80.28 | 66.06 |
| Inventory Days | 82.21 | 69.50 | 37.64 | 16.21 | 10.51 |
| Payable days | 624.41 | 492.96 | 761.23 | 619.39 | 401.50 |
| Valuation Parameters | |||||
| PER(x) | 30.57 | 21.33 | 23.31 | 25.69 | 18.13 |
| PCE(x) | 18.94 | 12.48 | 13.03 | 13.76 | 7.86 |
| Price/Book(x) | 2.57 | 1.56 | 1.44 | 1.31 | 0.63 |
| Yield(%) | 0.50 | 0.89 | 0.86 | 0.99 | 1.08 |
| EV/Net Sales(x) | 3.06 | 1.96 | 1.87 | 2.44 | 1.10 |
| EV/Core EBITDA(x) | 14.43 | 9.79 | 9.75 | 10.89 | 5.33 |
| EV/EBIT(x) | 19.60 | 13.98 | 15.07 | 17.61 | 8.32 |
| EV/CE(x) | 2.17 | 1.47 | 1.02 | 0.98 | 0.52 |
| M Cap / Sales | 2.75 | 1.79 | 1.80 | 2.53 | 1.03 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.01 | 15.16 | 62.21 | -11.49 | 5.32 |
| Core EBITDA Growth(%) | 23.25 | 19.93 | 39.01 | -3.76 | 8.00 |
| EBIT Growth(%) | 29.48 | 29.91 | 45.45 | -7.08 | 7.68 |
| PAT Growth(%) | 23.38 | 25.40 | 27.40 | 53.56 | -12.85 |
| EPS Growth(%) | 24.07 | 25.90 | 27.66 | 53.67 | -12.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.31 | 0.15 | 0.18 | 0.05 | 0.08 |
| Current Ratio(x) | 1.71 | 2.66 | 2.56 | 3.32 | 2.81 |
| Quick Ratio(x) | 0.98 | 1.71 | 1.86 | 3.03 | 2.62 |
| Interest Cover(x) | 8.28 | 10.66 | 11.51 | 13.13 | 8.66 |
| Total Debt/Mcap(x) | 0.12 | 0.10 | 0.12 | 0.04 | 0.12 |
Compare Financial Ratios of peers of SHALBY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHALBY | ₹2,039.6 Cr | -5.3% | -6.7% | -34.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹105,891.0 Cr | -4.1% | 13% | 37.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹97,373.9 Cr | 0.8% | 10.1% | 8.3% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹49,057.2 Cr | 0.1% | 4.6% | 50.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹34,751.6 Cr | 1.4% | 7.3% | 27.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹34,078.4 Cr | 2.9% | 5% | -11.2% | Stock Analytics | |
SHALBY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHALBY | -5.3% |
-6.7% |
-34.5% |
| SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses
